Thyroid cancer in Egypt: histopathological criteria, correlation with survival and oestrogen receptor protein expression
- PMID: 25576212
- DOI: 10.1007/s12253-014-9892-5
Thyroid cancer in Egypt: histopathological criteria, correlation with survival and oestrogen receptor protein expression
Abstract
Thyroid cancer represents approximately 1% of new cancer and oestrogen may play a role in the pathogenesis of thyroid neoplasm. We aimed to study the clinicopathological criteria and ER expression of thyroid cancer in Mansoura University (Egypt), and to correlate the survival to these clinicopathological data and ER expression. This retrospective study reviewed 644 patients with histologically proven thyroid carcinoma during the period from 2003 to 2011. 152 cases during the period between 2008 and 2011 were retrieved from the archive and examined by immunohistochemistry for oestrogen receptor-α (ER) expression. ER-α expression is significantly associated with the female sex, lymph node metastasis, TNM stage, extrathyroid extension, multifocality disease and recurrence and in the whole series (p < 0.5). The same was noticed in papillary carcinoma (PTC) except the gender of the patient. Tumour type, extrathyroid extension and ER expression were the independent prognostic factors of DFS, while in PTC, only ER expression was the independent one. The histological type was the only independent prognostic factor for OAS in the series were studied for ER expression, while extrathyroid extension was the only one that affected OAS of PTC. There was significant positive correlation with lymph node metastasis and ER expression in whole patient and PTC cases. No difference in survival between the low and high ranges of positive oestrogen expression. The prognosis of thyroid carcinoma in Egypt is similar to that occurs worldwide. ER-α expression was a significant prognostic marker for DFS in thyroid cancer and can be used as a predictive factor of lymph node metastasis.
Similar articles
-
High ALDH1A1 expression correlates with poor survival in papillary thyroid carcinoma.World J Surg Oncol. 2014 Feb 3;12:29. doi: 10.1186/1477-7819-12-29. World J Surg Oncol. 2014. PMID: 24485040 Free PMC article.
-
Oncoproteins and tumor progression in papillary thyroid carcinoma: presence of epidermal growth factor receptor, c-erbB-2 protein, estrogen receptor related protein, p21-ras protein, and proliferation indicators in relation to tumor recurrences and patient survival.Cancer. 1995 Nov 1;76(9):1643-54. doi: 10.1002/1097-0142(19951101)76:9<1643::aid-cncr2820760922>3.0.co;2-#. Cancer. 1995. PMID: 8635070
-
Expression of oestrogen-α receptor in papillary thyroid carcinoma and its association with metastasis.Malays J Pathol. 2020 Dec;42(3):415-422. Malays J Pathol. 2020. PMID: 33361723
-
A comparison of the clinicopathological features and prognoses of the classical and the tall cell variant of papillary thyroid cancer: a meta-analysis.Oncotarget. 2017 Jan 24;8(4):6222-6232. doi: 10.18632/oncotarget.14055. Oncotarget. 2017. PMID: 28009980 Free PMC article. Review.
-
Prognostic variables of papillary and follicular thyroid carcinoma patients with lymph node metastases and without distant metastases.Endocr Relat Cancer. 1999 Mar;6(1):109-15. doi: 10.1677/erc.0.0060109. Endocr Relat Cancer. 1999. PMID: 10732793 Review.
Cited by
-
Estrogen and thyroid cancer is a stem affair: A preliminary study.Biomed Pharmacother. 2017 Jan;85:399-411. doi: 10.1016/j.biopha.2016.11.043. Epub 2016 Nov 26. Biomed Pharmacother. 2017. PMID: 27899250 Free PMC article.
-
Decline in radioiodine use but not total thyroidectomy in thyroid cancer patients treated in the United Arab Emirates - A retrospective study.Ann Med Surg (Lond). 2021 Mar 4;64:102203. doi: 10.1016/j.amsu.2021.102203. eCollection 2021 Apr. Ann Med Surg (Lond). 2021. PMID: 33747499 Free PMC article.
-
Signaling Complexity Measured by Shannon Entropy and Its Application in Personalized Medicine.Front Genet. 2019 Oct 21;10:930. doi: 10.3389/fgene.2019.00930. eCollection 2019. Front Genet. 2019. PMID: 31695721 Free PMC article.
-
The Emerging Role of Estrogens in Thyroid Redox Homeostasis and Carcinogenesis.Oxid Med Cell Longev. 2019 Jan 9;2019:2514312. doi: 10.1155/2019/2514312. eCollection 2019. Oxid Med Cell Longev. 2019. PMID: 30728883 Free PMC article. Review.
-
Altered expression of estrogen receptor β2 is associated with different biological markers and clinicopathological factors in papillary thyroid cancer.Int J Clin Exp Pathol. 2015 Jun 1;8(6):7149-56. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26261608 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous